the aid library

LIST OPTIONS

Filter

7845

Uganda: Ebola Preparedness Emergency Plan of Action (EPoA) - DREF Operation n° MDRUG041

International Federation of Red Cross And Red Crescent Societies (2018) C1

Following the declaration of the 9th Ebola Disease Outbreak (EVD) on 8 May 2018 by the Democratic Republic of Congo (DRC) Ministry of Health, the WHO has raised the alert for neighbouring countries of the Democratic Republic of the Congo (DRC) which share extensive borders, hosting DRC refugees and ... more

Download (374)

View PDF (888)

‘ELIMU KWANZA!’ - A Brighter Future for the Children of DRC Safe Education for Internally Displaced Children in the Democratic Republic of Congo

War Child Holland War Child Holland (2014) C1

Prioritise education in conflict-affected areas: Across the world 28 million1 primary school-age children living in conflict-affected countries are out-of-school, and they form half of the world’s total out-of-school population. During conflict, infrastructure assets such as schools are damaged... more

Download (332)

View PDF (511)

Out of Silence. Women's mental health in their own words

National Women's Council of Ireland (2018) CC

Download (392)

View PDF (563)

Maintaining essential health services: operational guidance for the COVID-19 context
recommended

World Health Organization WHO (2020) C_WHO

1 June 2020 Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan... more

Download (294)

View PDF (466)

Western Pacific regional framework to end TB: 2021-2030

World Health Organization WHO (2022) C_WHO

his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care; ... more

Download (277)

View PDF (541)

WHO Timor-Leste Country Cooperation Strategy: 2021-2025

World Health Organisation (WHO) (2023) C_WHO

In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta... more

Download (451)

View PDF (452)

Supporting the routine use of evidence during the policy-making process: a WHO checklist

World Health Organisation (WHO) (2023) C_WHO

This checklist is for any organization or person supporting the routine use of evidence in the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH... more

Download (303)

View PDF (424)

Fit for purpose - Antiretroviral treatment optimisation

P. Clayden Unitaid; HIV i-Base (2018) C2

HIV i-Base July 2018

Download (356)

View PDF (326)

The Global strategy and action plan on ageing and health

World Health Organization WHO (2017) C_WHO

Specifically the Strategy focuses on five strategic objectives: commitment to action on Healthy Ageing in every country; developing age-friendly environments; aligning health systems to the needs of older populations; developing sustainable and equitable systems for providing lon... more

Download (252)

View PDF (285)

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

European Centre for Disease Prevention and Control ECDC (2020) CC

This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th... more

Download (326)

View PDF (434)

O papel dos agentes comunitários de saúde na vacinação contra a COVID-19: guia de apoio à implementaçao

Organização Mundial da Saúde (OMS); UNICEF (2021) C_WHO

The role of community health workers in the vaccination against COVID-19: guide to support the implementation of the vaccination programme

Download (478)

View PDF (664)

Trends in Child Health in Nigeria, 2003– 2013

Winter, Rebecca, Akinlo, Ambrose, and Lia Florey ICF International (2016) C2

DHS Further Analysis Reports No. 103

Download (450)

View PDF (640)

Living Conditions among People with Activity Limitations in Zambia: A National Representative Study.

Arne H Eide & ME Loeb SINTEF Health Research (2006) C1

This research report provides results from the study on living conditions among people with disabilities in Zambia. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Zambia are also compar... more

Download (427)

View PDF (403)

Saving Mothers, Giving Life. Maternal Mortality Endline Census in Selected Districts

Central Statistical Office (CSO) Zambia, Ministry of Health (MOH) Zambia, and ICF, et al. (2017) C1

Download (406)

View PDF (555)

WHO operational handbook on tuberculosis: module 2: screening: systematic screening for tuberculosis disease

World Health Organization WHO (2020) C_WHO

External Link

The path that ends AIDS: UNAIDS Global AIDS Update 2023
recommended

UN Children's Fund UNICEF (2023) CC

This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not... more

Download (256)

View PDF (247)

The Global State of Harm Reduction 2016

K. Stone; G. Sander Harm Reduction International (2016) C2

Download (470)

View PDF (696)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (602)

View PDF (775)

Epidemic meningitis surveillance in the African meningitis belt

World Health Organization WHO (2014) C_WHO

Download (638)

View PDF (1196)

Narok County: 2017 Long Rains Food Security Assessment Report (July 2017)

Government of Kenya (2017) C1

Maintaining essential health services: operational guidance for the COVID-19 context recommended

The path that ends AIDS: UNAIDS Global AIDS Update 2023 recommended

Maintaining essential health services: operational guidance for the COVID-19 context
recommended

The path that ends AIDS: UNAIDS Global AIDS Update 2023
recommended